Risto

Prostate cancer: Risto chose radiotherapy instead of surgery

Risto Laitinen, an active member of the Finnish Prostate Cancer Association, chose radiotherapy instead of surgery. Automation engineer and former sportsman Risto Laitinen supports other prostate cancer patients to ensure that they have the information they need to overcome their illness.

Prior to Risto Laitinen’s prostate cancer diagnosis, his PSA levels were monitored through routine checks performed by his occupational healthcare provider. For years, his PSA level was slowly rising. “At some point, I started having some prostate issues, but nothing bad. In 2008, I didn’t go for a PSA test, and in 2009, my PSA level was found to have risen quite a lot. I was referred for further testing, and a biopsy was taken. In March, the statement from the pathologist came. My urologist called me to tell me that I had prostate cancer.  An appointment was scheduled for me three weeks later.”

“I had been thinking that there was something going on. Still, when the result came, it felt unreal. I thought I was going to die. At the time, I didn’t know much about prostate cancer, but I started to research the topic when the biopsies were taken,” says Laitinen, who has later become an active member of the Finnish Prostate Cancer Association.

“My urologist told me that I would be treated with robot-assisted surgery. I tried to ask about alternative treatments but was told that surgery was the only option. He also informed me that I would lose my sexual abilities. It was a very brief appointment. After this, I started researching the topic and other treatment options. I visited another urologist to get a second opinion, and was once again advised that surgery was the solution. I called Hannu Tavio, who was the Executive Director of the Finnish Prostate Cancer Association Propo at the time. He asked if I had considered radiotherapy. I told him that such treatment had not been offered to me. Tavio advised me to visit Timo Joensuu, a specialist in cancer and radiotherapy, at Docrates Cancer Center to discuss different treatment options.”

Magnetic resonance imaging (MRI) is the best method for the determination of local spread of prostate cancer

“Timo Joensuu examined my entire PSA history, which is very important in monitoring and diagnosing prostate cancer.  PSA development differs from person to person. The PSA value itself does not tell you everything you need to know.  Based on how quickly my PSA levels had risen, Timo Joensuu suspected that this might be a case of high-risk cancer—higher than the statement from the pathologist had suggested. The test result may have been affected by the precision of the sampling. Timo Joensuu told me that my cancer might be Gleason 8–10 cancer in stage T3, which means that the tumor has grown through the prostate capsule,” Risto Laitinen explains.

I visited Docrates for an endorectal coil MRI scan in May 2009, when the new cancer center in Ruoholahti had only recently been equipped with the necessary equipment. The MRI scan revealed that the cancer was attached to the edge of the prostate capsule. In other words, Timo Joensuu’s suspicions turned out to be correct. Surgery was therefore not the best option as the fact that the cancer was attached to the edge of the capsule meant that radiotherapy would likely be necessary even after an operation. According to Timo Joensuu, efficient, high-quality and correctly targeted radiotherapy was the right treatment option for me,” Laitinen explains.

After the examinations at Docrates were completed, Risto Laitinen discussed the treatment options with Timo Joensuu several times and finally decided to have the treatments performed at Docrates as well. Hormone treatments began in late May, and external radiotherapy in June. At that time, Docrates had not yet started using tissue-internal radiotherapy, so-called HDR brachytherapy, which is a relatively new and efficient form of treatment that is suitable for the treatment of most types of prostate cancer under certain conditions. “The hormone treatments then continued for another six months, and after the treatments were completed, my PSA levels were monitored at Docrates,” Laitinen explains.

“Timo Joensuu told me that he would do everything he could for me. That made an impression. I developed a strong confidence in Joensuu’s expertise. “I came to Docrates from my home in Vantaa every day. I was able to schedule the treatments according to my needs and wishes.  I remember Timo Joensuu telling me, after the radiotherapy had started and the PSA levels began to decrease, that it looks good, as a quick decrease is a sign of successful treatment. To ensure that the cancer would not be able to spread, the lymph node area was also treated,” Risto recalls.

Post-treatment monitoring is important

After the radiotherapy treatment, the PSA level slowly starts rising again. This is a normal result of the prostate cells recovering and the destroyed cancer cells being replaced by new cells. The rise in PSA levels should be monitored regularly to se how quickly and to what level they rise. A very rapidly rising level may be a sign that the prostate cancer has returned or spread. For patients who have undergone prostate removal surgery, the PSA level should remain around zero after the operation.

Risto Laitinen recalls the rise in PSA levels and the side effects of the treatment: “My PSA levels began to rise quite moderately around a year after the radiotherapy and hormone treatments. In 2012, there were a couple of temporary PSA spikes, which, according to my understanding, were caused by antibiotics and antiviral medication. The hormone treatments caused side effects such as heavy sweating and frequent visits to the toilet for several months. The situation calmed down, but I gained some weight that seems to have stuck.”

An active volunteer in the Finnish Prostate Cancer Association Propo

Risto Laitinen is an active volunteer in the peer support network of the Finnish Prostate Cancer Association Propo. Before retiring around 10 years ago, Risto was a successful automation engineer, who also worked internationally. Risto has worked with things like elemental analyzers and X-ray physics, so the interest in cancer treatment has been there for a long time.

Risto became involved in Propo in 2009 as he himself had found it difficult to find proper information and support when he became ill. “Partly because of my educational background, I am a person who wants facts and information. The members of Propo Kamppi’s peer support group wanted more information about things such as different treatment options for prostate cancer. As I did not get help myself, it feels good to be able to help others,” Risto explains. In 2013–2014, Risto was a Board Member and Deputy Chair of Propo.

“Propo’s peer support evenings focus on peer support. The men can chat and exchange
experiences of prostate cancer, treatments and life after cancer. The partners of patients are also welcome to attend. We try to view the situation from the patient’s perspective. We can share our views on how the patient might move forward when it comes to examinations, treatment options and clinics, but it is always the patient who has to make the final decisions and choices. If necessary, we can also accompany patients to appointments and ask about things that are important to the patient. The participants in Propo’s peer support events are of all ages from 50 years upwards. We have also travelled together,” Risto continues.

In 2016, Risto was given a picture named “Elämän puu” (Tree of Life), created by Virpi Talvitie, as a form of recognition for his volunteer work.  The award is a reminder of how important the work of the volunteers is.

A happy man

“When I made the decision to choose radiotherapy instead of surgery, I felt a sense of relief for the first time. In the spring of 2009, I was told that I would be placed on the waiting list for a new robot-assisted operation, but the scheduling was not known because of summer holidays and other factors.  In other words, the situation was unclear. And there was also the question of what treatment to use when two doctors were of different opinions,” Risto recalls.

Docrates was able to treat him immediately. “The treatments and guidelines were very flexible at Docrates,” Risto says. “I am very happy with the treatment that Docrates has offered me.”

Risto was active in sports when he was younger. Those experiences continue to give him strength. He was even a Finnish youth pole vaulting champion in 1964. It is a great joy for Risto to be able to participate in the peer support work. “Member surveys have shown that our members are happy with the peer support group of Propo Kamppi. They receive information, and survey results have indicated that they consider the atmosphere here to be safe. New friendships are forged. The peer support activities help the participants feel better and constitute an important support network for many. I have also made new friends through Propo.” Risto encourages other men to participate in Propo’s meetings. “When participating in a peer support group, you are not alone with your illness.”

“I hope that my story can give others hope and confidence that it is possible to survive cancer.
I would once more like to thank the experts who have treated me.” Risto Laitinen

 

Why come to Docrates Cancer Center?

  • No waiting times: top cancer experts and effective treatments without delay
  • Individual care: you have your own care team - your doctor and your nurse
  • Front line cancer treatment: latest medical technology combined with proven expertise in cancer care
  • Experience in treating international patients: patients from over 60 countries, multilingual personnel
Contact us! +358 10 773 2050 Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (GMT +2)